Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
US Stock MarketDetailed Quotes
MAZE Maze Therapeutics
- 8.910
- -0.640-6.70%
Trading Apr 24 12:35 ET
390.22MMarket Cap114.23P/E (TTM)
9.760High8.750Low39.22KVolume9.650Open9.550Pre Close355.85KTurnover0.45%Turnover Ratio114.23P/E (Static)43.80MShares17.00052wk High-1.25P/B77.96MFloat Cap6.71052wk Low--Dividend TTM8.75MShs Float17.000Historical High--Div YieldTTM10.58%Amplitude6.710Historical Low9.072Avg Price1Lot Size
About Maze Therapeutics Company
Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM diseases. Its pipeline includes Compass platform, which allows to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process to refer a variant functionalization. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman on August 28, 2019 and is headquartered in San Francisco, CA.
Company Profile
SymbolMAZE
Company NameMaze Therapeutics
Listing DateJan 31, 2025
Issue Price16.00
Founded2017
CEODr. Jason V. Coloma, PhD
MarketNASDAQ
Employees125
Fiscal Year Ends12-31
Address171 Oyster Point Boulevard,Suite 300
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-850-5070
Websitehttp://www.mazetx.com
Company Executives
- Name
- Position
- Salary
- Dr. Jason V. Coloma, PhD
- Chief Executive Officer and Director
- 5.84M
- Atul Dandekar
- Chief Strategy and Business Officer
- --
- Dr. Harold S. Bernstein
- President, Research and Development and Chief Medical Officer
- 2.40M
- Amy Bachrodt
- Senior Vice Preisdent, Finance and Principal Accounting Officer
- --
- Dr. Charles J. Homcy,M.D.
- Chairman of the Board
- 1.12M
- Neil Exter, M.B.A.
- Independent Director
- --
- Daniel K. Spiegelman
- Independent Director
- 118.10K
- Dr. Sekar Kathiresan, M.D.
- Independent Director
- 119.32K
- Dr. Richard H. Scheller, PhD
- Independent Director
- 178.22K
- Dr. Nancy C. Andrews, M.D.,PhD
- Independent Director
- 113.43K
- Dr. Jonathan E. Lim,M.D.
- Independent Director
- 98.10K
- Dr. Catherine Angell Sohn, Pharm.D.
- Independent Director
- 113.43K
- Courtney J. Phillips
- General Counsel and Corporate Secretary
- 2.22M
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
